Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 23;10(1):3800.
doi: 10.1038/s41467-019-11716-6.

Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin

Affiliations

Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin

Koen Schipper et al. Nat Commun. .

Abstract

E-cadherin (CDH1) is a master regulator of epithelial cell adherence junctions and a well-established tumor suppressor in Invasive Lobular Carcinoma (ILC). Intriguingly, somatic inactivation of E-cadherin alone in mouse mammary epithelial cells (MMECs) is insufficient to induce tumor formation. Here we show that E-cadherin loss induces extrusion of luminal MMECs to the basal lamina. Remarkably, E-cadherin-deficient MMECs can breach the basal lamina but do not disseminate into the surrounding fat pad. Basal lamina components laminin and collagen IV supported adhesion and survival of E-cadherin-deficient MMECs while collagen I, the principle component of the mammary stromal micro-environment did not. We uncovered that relaxation of actomyosin contractility mediates adhesion and survival of E-cadherin-deficient MMECs on collagen I, thereby allowing ILC development. Together, these findings unmask the direct consequences of E-cadherin inactivation in the mammary gland and identify aberrant actomyosin contractility as a critical barrier to ILC formation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
E-cadherin loss drives cell extrusion towards the basal lamina. a Schematic overview of engineered alleles in Wcre;Cdh1F/F;mTmG mice. b, c Examination of GFP-positive Wcre activity in mammary glands of 6-week-old Wcre;mTmG female mice by immunofluorescence (IF) analysis (n = 6). b IF staining of GFP was examined in cytokeratin-8 (CK8)-positive luminal mouse mammary epithelial cells (MMECs) and c cytokeratin-14 (CK14)-positive myoepithelial cells. Scale bar, 10 µm. d Identification of E-cadherin inactivated MMECs by IF staining of E-cadherin, GFP, CK14, and CK8 in 6-week-old Wcre;Cdh1F/F;mTmG female mice (n = 6). Arrows indicate events of cell extrusion upon inactivation of E-cadherin. Scale bare, 10 µm. e Immunohistochemical detection of GFP-positive E-cadherin inactivated MMECs in mammary gland sections of 3-, 4-, and 6-month-old Wcre;Cdh1F/F;mTmG female mice and age-matched WCre;mTmG control mice (n= 3). Scale bar, 20 µm. f Examination of E-cadherin expression in mammary gland sections of 3-month-old Wcre;Cdh1F/F;mTmG female mice and age-matched Wcre;mTmG control mice by IF analysis of GFP, E-cadherin, CK14, and Hoechst. Asterisk indicates area of zoom. Scale bar, 50 µm. g Quantification of the amount of extruded GFP-positive cells in 3-month-old Wcre;Cdh1F/F;mTmG (n= 3) female mice and age-matched Wcre;mTmG (n= 3) control mice. Data are of nine images per group. h Quantification of the average size of extruded GFP-positive cell clusters in the mammary glands of Wcre;Cdh1F/F;mTmG mice at the ages of 3, 5, and 12 months. Data are of three mice per time point and 10 images per mouse. All data are depicted as mean ± standard deviation. All p values were calculated using an unpaired two tailed t-test. Source data are provided as a Source Data file
Fig. 2
Fig. 2
E-cadherin loss increases actomyosin contractility. a Still images derived from in vivo intravital imaging of the mammary gland of 8-week-old Wcre;mTmG and Wcre;Cdh1F/F;mTmG mice displaying GFP-positive Cre-switched MMECs and mTomato non-switched MMECs and stromal cells. Zooms reveal motile GFP-positive E-cadherin inactivated MMECs in Wcre;Cdh1F/F;mTmG mice. Scale bars, 20 µm. b Quantification of the percentage of GFP-positive motile cells among Wcre;mTmG (n=2) and Wcre;Cdh1F/F;mTmG (n = 3) mice. Data are of four and three images per group, respectively. c Still image of in vivo intravital imaging of Wcre;Cdh1F/F;mTmG mice demonstrates extensive cell blebbing of GFP-positive E-cadherin inactivated MMECs. Scale bar, 10 µm. d Quantification of the percentage of GFP-positive blebbing cells among Wcre;mTmG (n=2) and Wcre;Cdh1F/F;mTmG (n= 3) mice. Data are of four and three images per group, respectively. e Examination of myosin light chain (MLC) activity by IF analysis of pSer19 MLC in GFP-positive E-cadherin-deficient MMECs in 5-month-old Wcre;mTmG and Wcre;Cdh1F/F;mTmG mice. Scale bar, 20 µm. f Quantification of the amount of GFP+ pSer19 MLChigh cells Wcre;mTmG (n=3) and Wcre;Cdh1F/F;mTmG (n= 3) mice. Data are of 51 and 60 images, respectively. All data are depicted as mean ± standard deviation. All p values were calculated using an unpaired two tailed t-test. Source data are provided as a Source Data file
Fig. 3
Fig. 3
Actomyosin relaxation enables survival upon E-cadherin loss. a Merged brightfield and GFP images of MMECs isolated from Wcre;mTmG and Wcre;Cdh1F/F;mTmG female mice in the absence or presence of 10 µM Y-27632. Asterisks indicate areas of zoom, red dotted lines display outgrowth of E-cadherin-deficient MMECs. Zooms display altered cell adhesion in the absence or presence of Y-27632 of GFP-positive E-cadherin-deficient cells derived from Wcre;Cdh1F/F;mTmG female mice. Scale bar, 50 µm. b Western blot analysis of Wcre;mTmG and Wcre;Cdh1F/F;mTmG MMECs stained for E-cadherin and tubulin (loading control). c Western blot analysis of subclones derived from the Wcre;mTmG and Wcre;Cdh1F/F;mTmG MMECs stained for E-cadherin and tubulin (loading control). d Brightfield images of MMECs 3 h post seeding in the absence or presence of 10 µM Y-27632 or 10 µM blebbistatin. Scale bar, 20 µm. e Western blot analysis of pSer473 Akt, Akt, cleaved caspase-3, and actin (loading control) in Wcre;Cdh1F/F;mTmG subclones grown in the absence or presence of 10 µM Y-27632. f, g Representative images (f) and quantification (g) of clonogenic assays with Wcre;mTmG (circles) and Wcre;Cdh1F/F;mTmG (squares) subclones grown in the presence or absence of 10 µM Y-27632 or 10 µM blebbistatin (7 days after seeding the cells). Data are of three independent experiments with three clones per experiment. h Western blot analysis of WT FVB and Cdh1∆/∆ MMECs stained for E-cadherin and actin (loading control). i, j Representative images (i) and quantification (j) of clonogenic assays with Cdh1∆/∆ and WT control MMEC lines with or without 10 µM Y-27632. Data are of three independent experiments. k Representative images of immunoblots of active RhoA pull-down assays and ser19 myosin light chain phosphorylation (pMLC) from Cdh1∆/∆ and WT control MMECs harvested 3 h post seeding. l Quantification of active RhoA pull-down assays by densitometry normalized to the actin loading control. Data are of three independent experiments. All data are depicted as mean ± standard deviation. All p values were calculated using an unpaired two tailed t test. Source data are provided as a Source Data file
Fig. 4
Fig. 4
Balanced actomyosin contractility is essential for survival. a, b Representative images (a) and quantification (b) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMECs cultured with different concentrations of blebbistatin. Data are of three independent experiments with three clones per experiment. c, d Representative images (c) and quantification (d) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMECs cultured with different concentrations of H1152. Data are of three independent experiments with three clones per experiment. All data are depicted as mean ± standard deviation. Source data are provided as a Source Data file
Fig. 5
Fig. 5
MYPT1 drives actomyosin relaxation and cell adhesion. a Schematic overview of the doxycycline (dox) inducible t-MYPT1 (MYPT11–413) construct. b Western blot analysis of Wcre;Cdh1F/F;mTmG MMECs transduced with dox-inducible Flag-tagged t-MYPT1 in the absence, presence, or following washout of 2 mg/mL dox as stained for FLAG and actin (loading control). c, d IF staining (c) and quantification (d) of dox-inducible Flag-tagged t-MYPT1 Wcre;Cdh1F/F;mTmG MMECs cultured in the presence of 2 µg/mL dox or 50 h post washout stained for phospho myosin light chain (pMLC), actin, and Hoechst. Data are of 15 images per condition. e, f Representative images (e) and quantification (f) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMECs expressing Dox-inducible Flag-tagged t-MYPT1 cultured with or without 2 mg/mL dox and/or 10 µM Y-27632. Data are of three independent experiments with three clones per experiment. g Schematic overview of full-length MYPT1, t-MYPT1, and t-MYPT1ΔPP1 (MYPT192–413) displaying the PP1 recognition motif and the ankyrin repeats (ANK) domain, the leucizine zipper domain and inhibitory phosphorylation sites (T696 and T853). h, i IF staining (h) and quantification (i) of Wcre;Cdh1F/F;mTmG MMECs transduced with MYPT1-wt, t-MYPT1, t-MYPT1ΔPP1, or GFP 48 h post washout of 10 µM Y-27632 and stained for pMLC, actin, and Hoechst. Data are of 15 images per condition. j, k Representative images (j) and quantification (k) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMECs transduced with t-MYPT1, t-MYPT1ΔPP1 or GFP cultured in the presence or absence of 10 µM Y-27632 (7 days after seeding the cells). Data are of three independent experiments with three clones per experiment. All data are depicted as mean ± standard deviation. All p values were calculated using an unpaired two tailed t-test. Source data are provided as a Source Data file
Fig. 6
Fig. 6
Collagen I does not support adhesion upon loss of E-cadherin. a IF analysis of GFP (green), Laminin (red), and Keratin 8 (cyan) expression in mammary gland sections from 12-week-old Wcre;mTmG (top panels) and Wcre;Cdh1F/F;mTmG mice (middle and bottom panels). Scale bar is 20 µM b, c Representative images (b) and quantification (c) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMEC subclones seeded on laminin-coated wells or uncoated plastic wells. Data are of three independent experiments with three clones per experiment. d GFP immunohistochemistry staining combined with a methylene blue staining (collagen). Scale bar is 20 µM. e, f Representative images (e) and quantification (f) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMEC subclones seeded on laminin-coated or collagen I-coated wells in the presence or absence of Y-27632 (10 µM) or blebbistatin (10 µM). Data are of three independent experiments with three clones per experiment. gi Immunoblots (g) and quantifications (h, i) of active RhoA pull-down assays from Cdh1∆/∆ MMECs harvested 3 h post plating on laminin- or collagen I-coated plates. Data are of three independent experiments. j, k Representative images (j) and quantification (k) of clonogenic assays with Wcre;Cdh1F/F;mTmG MMECs transduced with t-MYPT1, t-MYPT1ΔPP1, or GFP cultured seeded on laminin-coated or collagen I-coated wells. Data are of three independent experiments with three clones per experiment. All data are depicted as mean ± standard deviation. All p values were calculated using an unpaired two tailed t-test. Source data are provided as a Source Data file
Fig. 7
Fig. 7
Relaxation of actomyosin contractility drives ILC formation. a Schematic representation of intraductal injections performed in WapCre;Cdh1F/F mice with high-titer lentiviruses produced from vectors encoding MYPT1-wt, t-MYPT1, t-MYPT1ΔPP1, or empty vector (EV). b Quantified tumor burdens of Wcre;Cdh1F/F females 20 weeks after intraductal injection of Lenti-EV (n = 16 glands), Lenti-MYPT1-wt, (n = 12 glands), Lenti-t-MYPT1 (n = 24 glands), or Lenti-t-MYPT1ΔPP1 (n = 14 glands). Data are depicted as mean ± standard deviation. p values were calculated using an unpaired two-tailed t-test. c Representative images of tumor sections stained with H&E or stained for E-cadherin and CK8 and Collagen (Sirius red). Scale bar is 20 µM. Source data are provided as a Source Data file

References

    1. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1994;1198:11–26. - PubMed
    1. Vleminckx K, Vakaet L, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991;66:107–119. doi: 10.1016/0092-8674(91)90143-M. - DOI - PubMed
    1. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 1989;108:2435–2447. doi: 10.1083/jcb.108.6.2435. - DOI - PMC - PubMed
    1. Vos CB, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer. 1997;76:1131–1133. doi: 10.1038/bjc.1997.523. - DOI - PMC - PubMed
    1. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3:467–488. doi: 10.1111/j.1365-2559.1979.tb03029.x. - DOI - PubMed

Publication types

MeSH terms